Finance

Lists
APLLTD:NSE
Alembic Pharmaceuticals Ltd
1 044,95 INR
-0,44%
(-4,65) 1D
20 ნოე, 15:30:03 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APLLTD...
Open
1 045,55 INR
High
1 053,80 INR
Low
1 034,90 INR
Mkt. cap
205,40 მლრ.
Avg. vol.
470,20 ათ.
Volume
191,25 ათ.
Dividend
1,15%
Quarterly dividend
3,00 INR
Ex-dividend date
29 ივლ. 2026
P/E ratio
24,35
52-wk high
1 075,00 INR
52-wk low
635,80 INR
EPS
42,92 INR
Shares outstanding
188,50 მლნ.
No. of employees
17 ათ.
Open
1 045,55 INR
High
1 053,80 INR
Low
1 034,90 INR
Mkt. cap
205,40 მლრ.
Avg. vol.
470,20 ათ.
Volume
191,25 ათ.
Dividend
1,15%
Quarterly dividend
3,00 INR
Ex-dividend date
29 ივლ. 2026
P/E ratio
24,35
52-wk high
1 075,00 INR
52-wk low
635,80 INR
EPS
42,92 INR
Shares outstanding
188,50 მლნ.
No. of employees
17 ათ.
News stories
From web sources and news partners
About Alembic Pharmaceuticals Ltd
CEO-
Employees17,2 ათ.
Founded1907
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Website-
Last report
4 ნოე. 2026
Fiscal period
Q2 2027
39,31 INR / 10,97 INR
+258,45%beat
Revenue / Est. (INR)
26,03 მლრდ. / 23,34 მლრდ.
+11,57%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
18,76 მლრდ.
18,48 მლრდ.
21,50 მლრდ.
26,03 მლრდ.
Cost of goods sold
5,29 მლრდ.
6,27 მლრდ.
6,20 მლრდ.
6,86 მლრდ.
Cost of revenue
5,29 მლრდ.
6,27 მლრდ.
6,20 მლრდ.
6,86 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,33 მლრდ.
4,39 მლრდ.
4,74 მლრდ.
5,04 მლრდ.
Operating expense
11,34 მლრდ.
10,85 მლრდ.
12,96 მლრდ.
14,55 მლრდ.
Total operating expenses
16,63 მლრდ.
17,11 მლრდ.
19,16 მლრდ.
21,41 მლრდ.
Operating income
2,13 მლრდ.
1,36 მლრდ.
2,34 მლრდ.
4,62 მლრდ.
Other non operating income
154,90 მლნ.
-285,60 მლნ.
149,30 მლნ.
151,20 მლნ.
EBT including unusual items
1,61 მლრდ.
1,19 მლრდ.
2,22 მლრდ.
4,38 მლრდ.
EBT excluding unusual items
2,04 მლრდ.
1,37 მლრდ.
2,22 მლრდ.
4,38 მლრდ.
Income tax expense
295,40 მლნ.
-829,00 მლნ.
495,00 მლნ.
1,04 მლრდ.
Effective tax rate
18,29%
-69,88%
22,31%
23,76%
Other operating expenses
6,21 მლრდ.
5,56 მლრდ.
7,24 მლრდ.
8,51 მლრდ.
Net income
1,33 მლრდ.
2,03 მლრდ.
1,73 მლრდ.
3,35 მლრდ.
Net profit margin
7,09%
10,97%
8,05%
12,87%
Earnings per share
8,51
11,57
8,80
39,31
Interest and investment income
-
8,60 მლნ.
-
-
Interest expense
-233,10 მლნ.
-225,60 მლნ.
-276,10 მლნ.
-382,60 მლნ.
Net interest expenses
-233,10 მლნ.
-217,00 მლნ.
-276,10 მლნ.
-382,60 მლნ.
Depreciation and amortization charges
801,20 მლნ.
885,90 მლნ.
977,10 მლნ.
1,01 მლრდ.
EBITDA
2,78 მლრდ.
2,12 მლრდ.
3,09 მლრდ.
5,62 მლრდ.
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google აპები